MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma

MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma

Abstract Background Glioblastoma (GBM) is a relatively prevalent primary tumor of the central nervous system in children, characterized by its high malignancy and mortality rates, along with the intricate challenges of achieving complete surgical resection. Recently, an increasing number of studies...

Full description

Bibliographic Details
Main Authors: Gen Li, Liya Ma, Chenxi Feng, Hongli Yin, Jianping Bao, Di Wu, Zimu Zhang, Xiaolu Li, Zhiheng Li, Chun Yang, Hairong Wang, Fang Fang, Xiaohan Hu, Mei Li, Lixiao Xu, Yunyun Xu, Hansi Liang, Tianquan Yang, Jianwei Wang, Jian Pan
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Cancer
Subjects:
GBM
BRD4
SEs
PROTAC
SDC1
Online Access:https://doi.org/10.1186/s12885-024-11966-8

Internet

https://doi.org/10.1186/s12885-024-11966-8

Similar Items